Interestingly, a recent study analyzing the prevalence of cytoskeletal actin mutations in cancer using the cBioPortal database found that mutations in ACTB and ACTG1 are associated with lymphoid cancers, specifically mutations in ACTB with diffuse large B-cell lymphoma and mutations in ACTG1 with multiple myeloma. This evidence concerns the gene ACTG1 and AL amyloidosis.